Top story Eli Lilly's Zepbound Gets a Significant Price Drop: What It Means for Patients and the Market
Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status
A New Horizon in Lung Cancer Treatment: FDA Grants Breakthrough Status to Lilly-Merck Combination Therapy
Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection
Prothena's PRX012 Alzheimer's Drug Shines with 'Non-Competitive' Brain Swelling Rates, Offering New Hope